Global Cell Line Development Services Market Value to near USD 12,957.8 Million by 2033 FMI Analysis

The demand for cell line development services is anticipated to grow at an average year-on-year growth rate of 7.4% during the years from 2023 to 2033. The new market analysis report by FMI estimates the adoption of cell line development services to be valued at nearly USD 6,365.2 million in 2023. Furthermore, according to FMI’s forecast, the market will be worth around USD 12,957.8 million by the end of this forecast period in 2033.

The demand for cell line development services saw a remarkable CAGR of 6.5% between 2018 and 2022, demonstrating its growing usage and acknowledgment of the value it supplies. The focus of biopharmaceutical businesses is on the creation of novel medicines, including vaccines, cell and gene therapies, and monoclonal antibodies. Specialized cell lines with the ability to precisely and effectively manufacture the appropriate products are necessary for these cutting-edge treatment methods.

An expanding range of applications, including drug discovery, biologics manufacturing, and personalized medicine, necessitate the use of efficient and trustworthy cell line creation services. So the ongoing research and technical developments in biotechnology are to blame for the enormous expansion of the overall market in recent years.

Key Takeaways from the Global Cell Line Development Services Market Study Report:

  • The demand for cell line development services in North America was estimated to be around 31.4% of the global demand in 2022. Meanwhile, the demand for cell line development services in Europe generated a revenue of around 25.3% that year.
  • Based on countries, the United States dominated the global market by capturing a global market share of 28.6% in the year 2022
  • The leading market for cell line creation services is in Europe was in Germany which captured a global market share of 5.3% in 2022. It was followed by the United Kingdom which is poised to grow at 6.6% CAGR over the next ten years.

Growing Market Interest: Explore Comprehensive Insights and Trends with Our Detailed Report!

Competitive Landscape for the Cell Line Development Services Market Players:

Ribbon BioLabs, Centarix Biotech, CytoRecovery, MicroByre, Leonyte Biosystems, spherefluidics, AcceGen, Bhat bio-tech India private limited, and Imgenex India are some top players in this market. To accommodate the rising demand during the Covid-19 pandemic, these leading service providers on the international market had rigorously expanded their commercial activities.

To improve their service offerings, existing as well as new cell line development service providers are investing heftily in research and development operations. This involves creating cutting-edge platforms and technologies that enable cell line creation that is quicker, affordable as well as more effective. Additionally, to serve a wider clientele and handle bigger projects, these suppliers are growing their infrastructure and capacities in many new regional markets.

Recent Developments by the Cell Line Development Services Providers:

In January 2023, Thermo Fisher Scientific SA released their new Cell Line Development Suite in January 2023. This complete collection of tools and services is intended to assist researchers in creating and refining cell lines. Likewise, WuXi Biologics Company announced the launch of its new cell line development facility in Singapore in February 2023.

To further expand their position in the market, service providers are proactively working with biopharmaceutical firms, academic institutions, and contract development and manufacturing organizations. For instance, Lonza and Selexis partnered to provide a new cell line creation service in January 2023. This partnership is aimed at combining Selexis’ unique cell line engineering platform with Lonza’s cell culture expertise.

Key Segments Profiled in the Cell Line Development Services Industry Survey:

By Product Type:

  • Media and Reagents
  • Equipment
  • Others Cell Line Development Service Products

By Type:

  • Primary Services
  • Continuous Services
  • Hybridomas Services
  • Recombinant Cell Line Development Services

By Application:

  • Bioproduction
  • Diagnostics
  • Vaccines
  • Recombinant Protein Therapeutics
  • Tissue Engineering & Regenerative Medicines
  • Drug Discovery
  • Toxicity Testing
  • Pharmaceutical and Biotechnology Research

By Region:

  • North America Market
  • Latin America Market
  • Europe Market
  • Asia Pacific Market
  • Middle East & Africa Market


About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Surgical Drainage Devices Market Set to Reach USD 2.9 Billion by 2032, Driven by Strong Growth in Active Drainage Devices | FMI

The global surgical drainage devices market has witnessed remarkable growth, with a valuation of USD 1.4 Billion in 2022, according to a newly-released report by Future Market Insights (FMI). The market is poised for significant expansion, with a compound annual growth rate (CAGR) of 7.7% from 2022 to 2032. By the end of the forecast period, the market is expected to reach a robust valuation of USD 2.9 Billion.

Key trends indicate that Active Drainage Devices will be the dominant segment in terms of revenue generation. This segment is anticipated to grow at an impressive CAGR of over 7.8% over the next decade, underlining the increasing preference for advanced, high-performance drainage solutions in both hospital and surgical settings.

Surgical drainage devices play a critical role in the recovery process for patients undergoing major surgeries, particularly in preventing fluid accumulation, thereby reducing the risk of complications. As surgical procedures become more complex and the demand for post-surgical care rises globally, the market for these devices is expected to continue its upward trajectory.

The increasing focus on minimally invasive procedures and advancements in medical technologies are expected to be key drivers of the market growth. Furthermore, the rising prevalence of chronic conditions requiring surgical intervention is likely to contribute significantly to the demand for surgical drainage devices.

The Future Market Insights report offers valuable insights into market trends, growth drivers, and key challenges, providing stakeholders with a comprehensive understanding of the evolving landscape of the global Surgical Drainage Devices Market.

Key Takeaways:

  • Global Market Growth: The global Surgical Drainage Devices Market was valued at USD 1.4 Billion in 2022, with projections to reach USD 2.9 Billion by 2032, growing at a CAGR of 7.7% from 2022 to 2032.
  • Active Drainage Devices Segment: The Active Drainage Devices segment is expected to lead the market, with a projected CAGR of over 7.8% from 2022 to 2032.
  • United States Market: The U.S. is forecasted to dominate the market, reaching USD 995.6 Million by 2032, with a notable absolute dollar growth of USD 530.5 Million. The market is expected to grow at a CAGR of over 8% from 2022 to 2032, driven by an increase in surgeries and healthcare facility development.
  • United Kingdom Market: The market in the UK is projected to reach USD 128 Million by 2032, growing at a CAGR of 7.4%, with an absolute dollar opportunity of USD 65 Million from 2022 to 2032.
  • Japan Market: Japan’s Surgical Drainage Devices Market is anticipated to reach USD 112 Million by 2032, with an 8.6% CAGR during the forecast period, and a projected absolute dollar opportunity of USD 62.5 Million.
  • South Korea Market: South Korea’s market is expected to see strong growth, with a CAGR of 8.7%, reaching USD 71.6 Million by 2032, and generating an absolute dollar opportunity of USD 40 Million.

Interest in Market Trends: Get Detailed Analysis and Insights with Our Comprehensive Report!

Competitive Analysis:

Key players in the Surgical Drainage Devices market include Acelity, Teleflex Incorporated, Cardinal Health, Medtronic, Cook Medical, Johnson & Johnson, B. Braun Melsungen AG, Smith & Nephew plc, Stryker, Becton Dickinson, and Centese.

Notable recent developments by leading surgical drainage device providers are as follows:

  • In October 2021, Centese launched the Thoraguard device, a self-cleaning chest tube designed to provide more precise measurements for monitoring patients recovering from heart or lung surgeries. This innovation is set to boost Centese’s presence and growth in the surgical drainage devices sector.
  • In April 2019, Smith & Nephew plc expanded its surgical drains portfolio with the acquisition of Osiris Therapeutics, Inc. This strategic move is expected to strengthen Smith & Nephew’s surgical drains business and enhance its wound care offerings.

Surgical Drainage Devices Market Segmentation:

By Product Type:

  • Active drains
  • Passive drains

By Application:

  • Thoracic and Cardiovascular Surgeries
  • Neurosurgical Procedures
  • Abdominal Surgery
  • Orthopedics
  • Other Applications

By End-Use:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa(MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Proton Pump Inhibitors Market Set for Strong Growth, Reaching USD 4.9 Billion by 2033, Driven by Rising Demand for GERD Treatments | FMI

The global proton pump inhibitors market is poised for impressive growth, according to the latest research from Future Market Insights. Valued at approximately USD 3.0 billion in 2023, the market is projected to expand at a compound annual growth rate (CAGR) of 5.2%, reaching USD 4.9 billion by 2033.

Omeprazole, a key drug in this category, currently dominates the market with a significant share of approximately 28.5% in 2022. This robust market presence highlights the increasing reliance on PPIs for managing conditions such as gastroesophageal reflux disease (GERD), a disorder that has seen a surge in diagnoses globally.

The market for Proton Pump Inhibitors (PPIs) is being driven by the increasing prevalence of gastrointestinal disorders. Conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and Helicobacter pylori infections are becoming more common worldwide. PPIs are widely prescribed to manage and treat these disorders effectively. As the number of individuals affected by gastrointestinal issues continues to rise, the demand for PPIs as a primary treatment option is also increasing. This trend underscores the importance of PPIs in addressing the growing burden of gastrointestinal disorders and highlights the significant role they play in improving patient outcomes and quality of life.

Strong research and development (R&D) activities are a key driver of the Proton Pump Inhibitor (PPI) market. Ongoing R&D efforts in the field of gastroenterology and drug development have led to the introduction of new and improved PPI formulations. These innovations, including novel drug delivery systems and enhanced efficacy profiles, attract healthcare professionals and patients alike. The continuous pursuit of advancements in PPI medications not only improves treatment options but also addresses the evolving needs of patients with gastrointestinal disorders. Consequently, the market for PPIs is propelled forward by the commitment to R&D, fostering innovation, and ultimately providing better therapeutic solutions for patients worldwide.

Key Takeaways from Market Study:

  • Omeprazole dominates the proton pump inhibitors (PPIs) market, holding a significant market share of 5% in 2022. This leading position is driven by various factors, including its widespread availability, proven efficacy, and comparatively lower cost compared to other PPI drugs.
  • The oral route of administration holds the leading position with a market share of 3% in 2022. Oral administration is the preferred method for delivering proton pump inhibitors due to its convenience, ease of use, and high patient acceptance. It allows for effective systemic delivery of the medication, contributing to its dominant position in the market.
  • Capsules are the leading dosage form with a market share of 2% in the global proton pump inhibitors market in 2022. Capsules offer advantages such as easy swallowing, accurate dosing, and protection of the medication from degradation. They are preferred by healthcare professionals and patients for their convenience and effectiveness in delivering proton pump inhibitors for treatment.
  • Generics held a 3% market value share in 2022 in the global proton pump inhibitors market based on prescription type. Generic proton pump inhibitors have gained prominence due to their cost-effectiveness, comparable efficacy, and availability as alternatives to brand-name medications.
  • North America leads the global market in terms of region accounting for 8% market share in 2022. This is attributed to factors such as the high prevalence of gastrointestinal disorders, well-established healthcare infrastructure, robust research and development activities, and strong market presence of key pharmaceutical companies.

“The demand for photon pump inhibitors is increasing due to the growing prevalence of gastroesophageal reflux disease (GERD) and the need for effective treatment options..” says an analyst of Future Market Insights.

Heightened Demand for Market Data: Our Full Report Provides Extensive Trend Analysis!

Market Competition

The market players active within this industry space are undertaking launch of new product to continue maintaining their market share in the global market.

  • On April 2022, Daewon Pharmaceutical launched Escorten, its inaugural proton-pump inhibitor (PPI) treatment, utilizing 10mg of esomeprazole magnesium trihydrate, effectively addressing gastric mucosal lesions in acute and chronic gastritis in Korea.
  • On March 25, 2021, Xiromed LLC, a generic division of Insud Pharmaceuticals, launched Omeprazole delayed-release capsules, 20mg, as a cost-effective alternative to Prilosec®. CEO Narasimhan Mani expressed their commitment to expanding the product portfolio.

Key Companies Covered:

  • AstraZeneca
  • Bayer AG
  • Cadila Pharmaceuticals
  • Eisai Inc.
  • GlaxoSmithKline PLC
  • Pfizer Inc.
  • Takeda Pharmaceuticals
  • Sanofi SA
  • Perrigo Company PLC
  • Dr. Reddy’s Laboratories
  • Redhill Pharma Limited
  • Cipla Limited

Key Segments Covered in Photon Pump Inhibitors Industry Research:

By Drug Type:

  • Esomeprazole
  • Omeprazole
  • Dexlansoprazole
  • Pantoprazole
  • Rabeprazole
  • Lansoprazole
  • Others

By Route of Administration:

  • Oral
  • Injectable

By Dosage Form:

  • Tablet
  • Capsules
  • Injection
  • Others

By Prescription:

  • Branded
  • Generics

By Indication:

  • Gastroesophageal Reflux Disease
  • Heartburn
  • Peptic ulcers
  • Others

Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Speciality Clinics

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Catheter-Associated Urinary Tract Infections Treatment Market to Grow at 3.0% CAGR, Projected to Reach USD 1.76 Billion by 2033

According to Future Market Insights, the global market for catheter-associated urinary tract infections treatment is poised for steady growth over the next decade. With a projected compound annual growth rate (CAGR) of 3.0%, the market value is expected to rise from USD 1.31 billion in 2023 to USD 1.76 billion by 2033.

The market experienced a valuation of USD 1.26 billion at the end of 2022, and the upward trajectory is expected to continue with a Year-on-Year (Y-o-Y) growth of 3.9% in 2023. This growth is attributed to the rising incidence of catheter-associated infections and an increasing demand for effective treatments, driven by advancements in medical technology and healthcare infrastructure worldwide.

Key Market Drivers:

  1. Rising CAUTI Incidence: As healthcare facilities expand, the use of catheters for patient care also increases, leading to higher incidences of urinary tract infections (UTIs) associated with catheter use. This drives the demand for specialized treatments.
  2. Technological Advancements in Treatment Options: Ongoing innovation in antimicrobial catheters, along with advanced infection control protocols, is expected to enhance treatment outcomes and reduce the risk of infections.
  3. Increased Healthcare Spending: Growing healthcare investments globally, particularly in emerging economies, will further contribute to market growth by improving access to healthcare services and treatments.

The market’s expansion is also supported by an increasing awareness of infection prevention strategies and the ongoing development of infection management solutions tailored to the needs of patients with indwelling catheters.

Looking Forward:

With its strong growth prospects, the catheter-associated urinary tract infections treatment market offers significant opportunities for key players in the healthcare and pharmaceutical sectors to invest in cutting-edge solutions. As the global healthcare landscape continues to evolve, stakeholders are expected to benefit from advancements in treatment options, contributing to an overall reduction in infection-related healthcare costs.

Key Takeaways:

  1. Market Growth Forecast: The global catheter-associated urinary tract infections (CAUTI) treatment market is expected to grow steadily, with a projected compound annual growth rate (CAGR) of 3.0%. The market value is estimated to increase from USD 1.31 billion in 2023 to USD 1.76 billion by 2033.
  2. S. Market Outlook: The U.S. accounted for 18.2% of the global market share in 2022, with an expected CAGR of 2.2% during the forecast period. The increasing prevalence of chronic illnesses like diabetes, kidney disease, and bladder cancer, which require catheter usage, is a key driver of market growth in the U.S.
  3. Rising Complicated UTIs: The growing use of urinary catheters, especially indwelling catheters, has contributed to the rise in complicated urinary tract infections (UTIs). These infections are harder to treat and present a greater risk of complications, driving demand for treatment solutions.
  4. India’s Market Dominance: India held 10.2% of the global CAUTI treatment market share in 2022. With a large and growing patient population (1.42 billion people), the incidence of CAUTIs is high, fueling demand for effective treatments.
  5. China’s Efforts to Combat CAUTIs: China, with a market share of 9.5% in 2022, has implemented several government initiatives to reduce healthcare-associated infections, including CAUTIs. These efforts focus on raising awareness, training healthcare providers, and supporting infection prevention measures in healthcare settings, contributing to increased demand for CAUTI treatments.

Enhanced Interest in Market Trends: Access In-Depth Analysis and Insights with Our Full Report!

Competitive Landscape:

The catheter-associated urinary tract infection treatment market is highly competitive. Market leaders are focusing on enhancing their presence in emerging markets through strategic partnerships, mergers, and acquisitions, while also emphasizing the launch of innovative, technologically advanced products. The competitive environment is shaped by a combination of global and local players who hold a significant share of the market, with key activities including mergers, acquisitions, and collaborations with prominent market participants.

Notable developments include:

  • In June 2019, Merck announced a definitive agreement with Tilos Therapeutics to co-develop drugs for the treatment of cancer, fibrosis, and autoimmune diseases.
  • In November 2018, Allergan revealed that the FDA had accepted the Supplemental New Drug Application for Avycaz, aimed at treating patients with Complicated Urinary Tract Infections (CUTI) and Complicated Intra-Abdominal Infections (CIAI).

Key Companies Covered:

  • Pfizer Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline (GSK)
  • AstraZeneca
  • Bayer AG
  • Johnson & Johnson
  • Novartis International AG
  • Sanofi
  • Roche Holding AG
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • Abbott Laboratories
  • Astellas Pharma Inc.
  • Boehringer Ingelheim
  • Daiichi Sankyo Company, Limited

Key Segments Covered in Urinary Tract Infections Treatment Industry Research:

Drug Type:

  • Penicillin & Combinations
    • Amoxicillin
    • Amoxicillin+ Clavulanate Potassium
    • Others
  • Quinolones
    • Ciprofloxacin
    • Levofloxacin
    • Nalidixic acid
    • Norfloxacin
    • Others
  • Cephalosporin
    • Ceftriaxone
    • Cefuroxime
    • Cefixime
    • Cephalexin
  • Aminoglycoside Antibiotics
    • Amikacin
    • Gentamicin
  • Sulphonamides (Sulfamethoxazole +Trimethoprim)
  • Azoles and Amphotericin B
  • Tetracycline (Doxycycline)
  • Nitrofurans (Nitrofurantoin)
  • Other

Indication Type:

  • Asymptomatic CAUTI (Bacteriuria)
  • Symptomatic CAUTI (Bacteremic)

Distribution Channel:

  • Hospital Pharmacies
  • Gynaecology and Urology Clinics
  • Drug Stores
  • Retail Pharmacies
  • Online Drug Stores

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global 3D Printing Dental Device Market Set to Surge USD 8.2 Billion by 2033 grow at a CAGR of close to 16.4%

In a groundbreaking revelation by Future Market Insights, the global 3D printing dental device market is on the brink of unprecedented growth. With a valuation of USD 1.8 billion in 2023, the market is forecasted to skyrocket at a remarkable compound annual growth rate (CAGR) of 16.4%, reaching an estimated USD 8.2 billion by 2033.

The surge in market value is primarily attributed to the accelerating adoption of digital dentistry, a trend gaining significant traction among dental technicians, practitioners, and patients worldwide. The landscape of dental care is undergoing a paradigm shift, fueled by advancements in digital hardware. This revolution has transformed the operational dynamics for dental professionals, empowering them with sophisticated computer technologies to design and fabricate precise dental prostheses including abutments, implants, crowns, and bridges.

This shift towards digital methodologies is enhanced by the capabilities of CAD/CAM systems, which not only tailor dental prostheses to meet individual needs but also significantly reduce turnaround times and improve overall procedural accuracy.

The market’s trajectory is further bolstered by an increasing inclination towards 3D printing technologies in the creation of intricate dental models, including surgical guides, bridges, crowns, implants, and dentures. The rapid pace of technological advancements in this field is set to redefine and enhance dental practices globally.

As the dental industry continues to embrace innovative technologies, the 3D printing dental device market is expected to expand, bringing about transformative changes to dental diagnostic and treatment procedures. This growth signals a substantial shift towards more efficient, precise, and personalized dental care, promising improved outcomes for patients worldwide.

Key Takeaways from Market Study:

  • Product and services are dominant within the global market with a market share of 9% in 2022. This is attributed to the growing prevalence of dental conditions and simultaneously, higher adoption of 3D printed products.
  • Among various materials used for 3D printing, metals are the leading segment holding about 9% market share in 2022, owing to their exceptional blend of robustness, longevity, biocompatibility, visual appeal, and production proficiency.
  • By region, Europe is leading in the global 3D printing dental device market with a 0% market share in 2022. It is expected to continue to do so during the forecasted years due to the increasing prevalence of dental disorders.

“Increasing adoption of the digital dentistry and cost-effective treatment for dental conditions, are driving the growth of the 3D printing dental device market” says an analyst of Future Market Insights.

Demand for Market Analysis: Our Comprehensive Report Offers Detailed Trends and Insights!

Market Competition:

To advance research and development initiatives, manufacturers are increasingly prioritising collaboration with academic institutions, research organisations, and other research personnel. Manufacturers are implementing comprehensive innovation and marketing strategies to improve product accessibility, visibility, and awareness among healthcare professionals.

  • On February 22nd, 2022, Renishaw hosted an event highlighting its wide-ranging products in additive manufacturing. The event also showcased the advantages of metal 3D printing in the dental sector. The exhibition took place in Chicago.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the 3D printing dental device market in its latest study, presenting a historical demand assessment of 2017 – 2022 and projections for 2023 – 2033. The global 3D printing dental device market is segmented in detail to cover every market aspect and present a complete market intelligence approach to the reader.

The research study is based on the 3D printing dental device market by components– (3D printing systems {SLM, Other}, product and services {removable partial dentures, dental crowns & bridges, dental implants}, and by material– {metals, [non-precious metal alloys (cobalt chromium alloy, Ti-based alloys, stainless steel) and precious metal alloys}, ceramics}), across seven regions of the world.

Key Companies Covered:

  • 3D Systems
  • SprintRay
  • Ackuretta
  • Asiga
  • Renishaw
  • Formlabs Inc. (U.S.)
  • Sterngold Dental LLC
  • Desktop Metal
  • Institut Straumann Group
  • Stratasys Ltd
  • Höganäs AB
  • Eplus3D Tech Co., Ltd
  • Bego USA, Inc.
  • Dentsply Sirona Inc.
  • SLM Solutions

Key Segments Covered in 3D Printing Dental Device Industry Research:

By Component:

  • 3D Printing Systems:
    • SLM
    • Others
  • Products and Services:
    • Removable Partial Dentures
    • Dental Crowns & Bridges
    • Dental Implants
  • Materials:
    • Metals
      • Non-Precious Metal Alloys
        • Cobalt Chromium Alloy
        • Ti-Based Alloys
        • Stainless Steel
      • Precious Metal Alloys
    • Ceramics

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Interleukin-6 (IL-6) Inhibitors Market to Surge at a 10.9% CAGR, Projected to Reach USD 93.3 Billion by 2033

According to a recent research report by Future Market Insights, the global Interleukin-6 (IL-6) inhibitors market is on a robust growth trajectory, with an expected compound annual growth rate (CAGR) of 10.9% during the forecast period. The market, valued at USD 33.3 billion in 2023, is anticipated to reach a remarkable USD 93.3 billion by 2033.

In 2022, the market was valued at USD 30.2 billion, and it is projected to exhibit year-on-year (Y-o-Y) growth of 10.2% in 2023. This upward trend reflects the increasing demand for IL-6 inhibitors, which play a critical role in the treatment of autoimmune diseases, cancer, and other chronic conditions by targeting the IL-6 cytokine responsible for inflammation.

The surge in market value can be attributed to the rising prevalence of diseases such as rheumatoid arthritis, systemic lupus erythematosus, and cytokine release syndrome, coupled with advancements in drug development. The growing adoption of targeted therapies and the expanding pipeline of IL-6 inhibitors are expected to drive significant market expansion in the coming years.

Leading pharmaceutical companies are investing in the research and development of innovative IL-6 inhibitors, propelling the growth of this dynamic market. Additionally, the increasing awareness about autoimmune disorders and the growing preference for biologics over traditional treatments are key factors contributing to market growth.

As the IL-6 inhibitors market continues to expand, stakeholders across the healthcare and pharmaceutical sectors are poised to benefit from the significant opportunities arising in this high-growth therapeutic area.

Key Takeaways:

  1. Strong Market Growth: The global Interleukin-6 (IL-6) inhibitors market is poised for significant expansion, with a projected compound annual growth rate (CAGR) of 10.9% from 2023 to 2033, growing from USD 33.3 billion in 2023 to an estimated USD 93.3 billion by 2033.
  2. USA Leading the Market: The United States holds a dominant position in the global IL-6 inhibitors market, contributing 51.4% of the market share in 2022. This is due to a high prevalence of autoimmune diseases such as rheumatoid arthritis (RA) and osteoarthritis, an advanced healthcare system, and the presence of major pharmaceutical companies like Novartis, AbbVie, and Eli Lilly.
  3. UK’s Lucrative Market: The United Kingdom is a key player in the European IL-6 inhibitors market, accounting for 4.4% of the global market share in 2022. The UK’s advanced healthcare infrastructure, supportive regulatory environment, and rising disease prevalence contribute to the growing demand for IL-6 inhibitors.
  4. Japan’s Emerging Market: Japan is experiencing strong growth in the East Asian IL-6 inhibitors market, with a market share of 6.2% in 2022. Factors driving this growth include the aging population, increasing chronic disease rates, and a surge in research and development activities focused on biologics like IL-6 inhibitors for treating rheumatoid arthritis and cancer.

Growing Market Interest: Explore Comprehensive Insights and Trends with Our Detailed Report!

Competitive Landscape:

Major players in the interleukin-6 (IL-6) inhibitors market are placing a strong emphasis on research and development to solidify their market position and expand their reach in emerging markets. To strengthen their competitive edge, many manufacturers are adopting strategies such as forming partnerships and collaborations with research institutions and other industry players.

For example, in December 2022, the U.S. Food and Drug Administration (FDA) approved the use of IV tocilizumab for the treatment of COVID-19 in hospitalized patients who were receiving systemic corticosteroids.

Key Companies Profiled:

Novartis AG; AbbVie Inc.; Eli Lilly and Company; Regeneron Pharmaceuticals, Inc.; Johnson & Johnson Services, Inc.; F. Hoffmann-La Roche; Sanofi; GlaxoSmithKline Plc; AstraZeneca plc; Investor AB; Genentech

Key Segments Covered in Interleukin6 – il6- Inhibitors Market Industry Research:

By il-6 Inhibitor:

  • Tocilizumab
  • Siltuximab
  • Sylvant

By Disease:

  • Rheumatoid Arthritis
  • Castleman’s disease
  • Cancers

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Retinal Gene Therapy Market to Reach USD 235.4 Million by 2033, Driven by Innovation and Growing Demand for Treatments | FMI

The global retinal gene therapy market is set to experience robust growth in the coming years, fueled by increasing demand for advanced treatments for inherited retinal diseases. Recent market research indicates that the market will expand at a Compound Annual Growth Rate (CAGR) of 9.2% during the forecast period, reaching a projected value of USD 235.4 million by 2033.

The surge in the incidence of inherited retinal conditions, such as age-related macular degeneration (AMD), Stargardt disease, retinitis pigmentosa, and other genetic forms of blindness, has created a large, underserved patient population. This high unmet medical need has prompted the development of innovative gene therapies aimed at addressing these conditions.

Key Drivers of Market Growth:

  1. Rising Prevalence of Inherited Retinal Diseases: The growing number of individuals affected by retinal diseases globally has sparked a demand for new treatment options, positioning retinal gene therapy as a promising solution to restore vision and improve quality of life.
  2. Advances in Gene Therapy Technology: Ongoing advancements in gene therapy research and development have accelerated the implementation of retinal gene therapies, allowing for more effective and targeted delivery methods. These breakthroughs hold the potential to revolutionize the treatment of retinal diseases.
  3. Supportive Regulatory Frameworks and Government Funding: Favorable regulatory policies, combined with strong governmental support and funding for retinal gene therapy research, are propelling the market forward. This support has encouraged both private and public investments, fostering innovation in the field.
  4. Geographic Expansion and Vision Research Opportunities: Emerging markets and expansion into new geographic regions offer substantial growth opportunities for the retinal gene therapy industry. Additionally, the potential for novel therapies outside the traditional gene therapy space presents exciting possibilities for advancing vision research and treatment.

The retinal gene therapy market is on a trajectory of rapid growth, with the potential to deliver groundbreaking therapies for patients suffering from inherited retinal diseases and other forms of blindness. As the market continues to evolve, it is poised to achieve new milestones, providing hope for millions of individuals worldwide.

Key Takeaways from Market Study:

  • By indication, Stargardt disease segment held a prominent market share of about 8% in the global market, in 2022 owed to its high prevalence creating high demand for retinal gene therapy.
  • By end user, hospitals held a market share of around 6% in 2022 as they provide specialization and expertise in delivering the therapy.
  • North America dominated the global market with U.S. contributing around USD 30.8 Million in 2022.

“Technological advancements and increasing capital investment in research and development efforts by the government and private organizations to create lucrative opportunities for the retinal gene therapy market throughout the forecast period,” says an analyst of Future Market Insights.

Retinal Gene Therapy Trends on the Rise: Uncover the Full Scope with Our In-Depth Report!

Market Competition:

The market is characterized by a high level of market concentration, with a few key players dominating the market. However, these key players aim to promote innovation via continuous developments of new therapeutic pipelines and strategic collaborations, driving competition, and new commercial opportunities.

  • In October 2020, Novartis acquired Vedere Bio, a company that specializes in optogenetics and AAV gene therapy.

Key Companies Profiled:

  • Gyroscope Therapeutics (Novartis)
  • Applied Genetic Technologies Corporation (AGTC)
  • Spark Therapeutics
  • Adverum Biotechnologies
  • REGENXBIO Inc.
  • Biogen Inc.
  • Nightstar Therapeutics
  • MeiraGTx Holdings plc
  • GenSight Biologics
  • RetroSense Therapeutics
  • Second Sight Medical Products
  • Oxford Biomedica
  • Hemera Biosciences
  • Adverio Pharmaceuticals

Key Market Segments Covered in Retinal Gene Therapy Market Industry Analysis:

By Indication:

  • Leber Congenital Amaurosis (LCA)
  • Stargardt Disease
  • Choroideremia
  • X-linked Retinitis Pigmentosa (RP)
  • Others

By End User:

  • Hospitals
  • Academic & Research Institutes
  • Ophthalmic Clinics
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Transforming Tire Safety and Efficiency: Key Drivers and Trends in the Automatic Tire Inflation System Industry | FMI Reports

Automatic Tire Inflation System Industry

Automatic Tire Inflation System Industry

The Automatic Tire Inflation System industry is projected to be valued at USD 2,178.1 million in 2023 and is expected to grow to USD 3,755.9 million by 2033. The market is anticipated to expand at a CAGR of 5.6% during the forecast period from 2023 to 2033.

The Automatic Tire Inflation System (ATIS) industry is transforming vehicle safety and performance by ensuring optimal tire pressure in real-time. This technology, which automatically maintains tire pressure within a pre-set range, enhances vehicle safety, improves fuel efficiency, and extends tire lifespan. The ATIS industry is gaining traction as an essential component in both commercial and passenger vehicles due to its potential to reduce maintenance costs, boost fuel economy, and prevent tire-related accidents.

With growing safety regulations, advancements in sensor technology, and increasing awareness of the importance of tire maintenance, the demand for automatic tire inflation systems is expanding. This technology offers substantial benefits, including reducing tire wear, improving fuel efficiency, and enhancing the overall driving experience. The industry is further driven by the push for integrated vehicle technologies and the development of advanced electronic systems that enable real-time monitoring and control.

As the automotive industry evolves, the ATIS market is positioned to grow, fueled by the integration of ATIS with IoT, AI, and telematics. These integrations allow for seamless data collection and analysis, providing valuable insights for fleet management and predictive maintenance. The continued focus on road safety and environmental sustainability is reinforcing the growth of this sector, making ATIS a key innovation in modern vehicle management.

Key Drivers:

  • Safety Regulations and Standards: Increasing emphasis on vehicle safety and regulations that mandate or encourage technologies that reduce tire-related accidents are driving ATIS adoption.
  • Rising Fuel Prices and Efficiency Demands: As fuel prices remain a concern for both consumers and businesses, ATIS systems that optimize tire pressure and improve fuel economy are becoming more attractive.
  • Technological Advancements in Sensors and IoT: Innovations in sensors, wireless communication, and IoT are enabling more efficient and reliable automatic tire inflation systems.
  • Awareness of Tire Maintenance Benefits: Growing awareness about the impact of tire pressure on vehicle performance, safety, and fuel efficiency is boosting the adoption of ATIS.
  • Fleet Management and Logistics Needs: The commercial sector’s increasing demand for effective fleet management and operational cost reduction is driving the adoption of ATIS to prevent downtime and reduce tire maintenance costs.
  • Integration with Advanced Vehicle Systems: The synergy between ATIS and modern vehicle telematics, AI, and data analytics allows for more sophisticated monitoring and predictive maintenance capabilities.
  • Environmental and Cost-Saving Concerns: The emphasis on reducing carbon emissions and improving fuel efficiency to lower overall operating costs is influencing vehicle manufacturers and operators to implement ATIS.

Exhaustive Market Report: A Complete Study

Key Takeaways:

  • The Automatic Tire Inflation System industry is poised for growth as safety regulations, fuel efficiency requirements, and advancements in vehicle technologies continue to drive its adoption.
  • ATIS enhances vehicle safety by maintaining optimal tire pressure, which in turn reduces the risk of blowouts and tire-related accidents, contributing to road safety.
  • The integration of IoT and sensor technologies is facilitating real-time monitoring, enabling vehicle operators to maintain tire performance and predict maintenance needs.
  • The commercial vehicle sector, driven by fleet management and logistics needs, represents a significant market segment for ATIS, as it helps reduce tire maintenance costs and improve fuel economy.
  • Consumer awareness of tire maintenance and fuel efficiency is pushing the demand for ATIS systems, encouraging automakers to adopt and integrate this technology into new vehicle models.
  • The continued focus on environmental sustainability and cost savings is reinforcing the importance of ATIS in reducing fuel consumption and operational expenses.

Competitive Landscape

The key strategies chosen by large companies include several growth strategies such as technology development, expansion as well and mergers and acquisitions to surge market share, reach and revenue.Dana Incorporated; Meritor, Inc.; EnPro Industries, Inc.; Nexter Group; Servitech Industries, Inc.; Hendrickson USA, LLC; Tire Pressure Control International Ltd.; PTG Reifendruckregelsysteme GmbH; Aperia Technologies, Inc.; Systems GmbH; Bigfoot Equipment Ltd.; Tibus Offload Ltd. & Co. KG; AIR CTI; FTL Technology Limited; Col-Ven S.A.

  • In 2023, BFGoodrich Tires introduced the BFGoodrich® ActivAir, a fully integrated tire inflation system designed to enhance off road capabilities. The system enables drivers to adjust tire pressure without leaving their seats, offering convenience and flexibility in various off road situations.
  • In 2023, Danfoss Editron partnered with Meritor Inc. and Electra Commercial Vehicles to widen its product portfolio and offer a complete ATIS solution for electric commercial vehicles.
  • In 2022, EnPro Industries acquired Bridgestone Commercial Solutions, a leading provider of ATIS for commercial vehicles. The acquisition expands the product portfolio of the company and strengthens its position in the ATIS market.
  • In 2021, John Deere launched its 8R series tractor with a home built ATIS system integrated as an option.

Key Segmentation for the Automatic Tire Inflation System Industry

The Automatic Tire Inflation System (ATIS) industry can be segmented based on various factors that reflect the different aspects of the market and its applications. Understanding these segments helps businesses, investors, and stakeholders to navigate and target their strategies effectively. Below are the main segments that define the ATIS industry:

1. By Vehicle Type

  • Passenger Vehicles: Includes cars and SUVs, where ATIS can help in maintaining optimal tire pressure for better fuel efficiency, safety, and tire lifespan.
  • Commercial Vehicles: Such as trucks, buses, and vans, where maintaining tire pressure is critical for safety, fuel economy, and overall vehicle performance.
  • Off-Road Vehicles: Used in mining, construction, and agriculture, where tire performance is essential for demanding terrains and heavy-duty applications.
  • Electric Vehicles (EVs): A growing segment, as the need for efficient tire management aligns with the broader push for sustainable and energy-efficient solutions.

2. By Technology

  • Central Tire Inflation Systems (CTIS): Systems that allow for real-time inflation and deflation of tires to adjust to different road and weather conditions.
  • Automatic Tire Pressure Monitoring Systems (TPMS): Systems that provide real-time tire pressure data and may include automatic inflation features to maintain optimal pressure.
  • Direct Inflation Systems: Use sensors and automatic valves to ensure tires remain properly inflated without manual intervention.
  • Indirect Inflation Systems: Use a combination of wheel sensors and vehicle data to estimate tire pressure, triggering alerts for inflation when necessary.

3. By Component

  • Compressor Units: Essential for generating the air pressure needed to inflate tires.
  • Control Units: The electronic system that monitors and adjusts tire pressure in real-time.
  • Sensors and Valves: Used to measure tire pressure and control air flow to maintain proper inflation levels.
  • Pneumatic Lines and Connectors: Infrastructure that links various components to create a functioning inflation system.

4. By End-Use Application

  • Transportation and Logistics: ATIS play a significant role in ensuring the safety and efficiency of commercial transport vehicles, reducing fuel consumption and tire wear.
  • Mining and Construction: Vital in maintaining tire performance under harsh conditions, which helps reduce downtime and maintenance costs.
  • Agriculture: Used in tractors, harvesters, and other farming equipment where consistent tire pressure helps with traction and efficiency.
  • Military and Defense: Where tire integrity is crucial for vehicle performance in varied terrains and mission-critical operations.

5. By Sales Channel

  • OEM (Original Equipment Manufacturer): ATIS integrated into vehicles during manufacturing.
  • Aftermarket: Systems sold as upgrades or retrofits to existing vehicles, catering to consumers looking for enhanced vehicle performance and safety.

6. By Region

  • North America: Driven by the demand for commercial vehicles and regulatory requirements for safety and fuel efficiency.
  • Europe: Known for stringent environmental and safety regulations, boosting demand for advanced tire management systems.
  • Asia-Pacific: The largest market due to the significant production and adoption of commercial and passenger vehicles, coupled with rapid urbanization.
  • Middle East and Africa: Growing demand for commercial and off-road vehicles in infrastructure and mining projects.
  • Latin America: Emerging markets with increasing transportation and infrastructure needs.

7. By Type of Inflation

  • Single-Point Inflation: Inflates all tires simultaneously at a set pressure.
  • Individual Tire Inflation: Allows for individual tire pressure adjustment, providing greater control over tire health and fuel economy.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Automotive Microcontroller Industry: Driving the Future of Smart Vehicles | FMI Reports

Automotive Microcontroller Industry
Automotive Microcontroller Industry

The automotive microcontroller industry is projected to be valued at USD 14.32 billion in 2024. It is expected to grow at a CAGR of 8.27% throughout the forecast period, with the industry reaching an estimated value of nearly USD 31.7 billion by 2034.

The Automotive Microcontroller Industry is experiencing remarkable growth, fueled by the surge in demand for advanced automotive electronics, smart vehicle functionalities, and the rapid transition to electric vehicles (EVs). Automotive microcontrollers, essential for vehicle control systems, ensure enhanced safety, connectivity, and energy efficiency, positioning them at the core of modern automotive innovation.

As the automotive industry embraces autonomous driving technologies, connected vehicles, and stringent emission regulations, the role of microcontrollers in enabling these features is becoming increasingly critical. Manufacturers are focusing on developing high-performance, energy-efficient, and secure microcontrollers to meet the dynamic needs of next-generation vehicles.

Key Drivers of Growth

  • Increased Adoption of Advanced Driver Assistance Systems (ADAS): The growing integration of safety features such as lane-keeping assist, adaptive cruise control, and automated parking relies heavily on automotive microcontrollers.
  • Rising Demand for Electric Vehicles: EVs require sophisticated microcontrollers for battery management, motor control, and overall system efficiency, driving significant demand.
  • Proliferation of Connected Cars: The expansion of IoT in the automotive sector, including vehicle-to-everything (V2X) communication, is boosting the need for powerful microcontrollers.
  • Regulatory Compliance: Stringent emission standards and safety regulations globally necessitate advanced control systems powered by microcontrollers.
  • Technological Advancements: Development of low-power, high-performance microcontrollers with enhanced processing capabilities supports modern vehicle architectures.

Exhaustive Market Report: A Complete Study

Key Takeaways

  • Industry Growth: The automotive microcontroller Industry is projected to grow at a CAGR of 8% from 2023 to 2030, with Industry revenues anticipated to surpass USD 20 billion by 2030.
  • Dominant Applications: ADAS and electric powertrains are the leading application areas, accounting for a substantial share of microcontroller usage.
  • Regional Insights: Asia-Pacific leads the Industry, driven by high automotive production in countries like China, Japan, and India, while North America and Europe show steady growth due to strong adoption of advanced automotive technologies.
  • Focus on Security: The increasing need for cybersecurity in connected vehicles is driving the development of secure automotive microcontrollers.
  • Electrification Trends: As automakers invest heavily in EVs, microcontroller manufacturers are focusing on energy-efficient solutions tailored for electric powertrains.

Key Players

  • Texas Instruments Incorporated
  • NXP Semiconductors NV
  • STMicroelectronics NV
  • Microchip Technology Inc.
  • Renesas Electronics Corporation
  • Silicon Labs Private Limited
  • Fujitsu Limited
  • Maxim Integrated Products, Inc.
  • Infineon Technologies
  • Toshiba Corporation

Key Segments Covered in the Automotive Microcontroller Industry Survey Report

By Material Type:

  • Tinned Steel
  • Nickel-Cobalt Ferrous Alloy
  • Copper Alloy

By Vehicle Type:

  • Compact Passenger Cars
  • Mid-sized Passenger Cars
  • Premium Passenger Cars
  • Luxury Passenger Cars
  • Light Commercial Vehicles
  • Heavy Commercial Vehicles
  • Electric vehicle

By Application:

  • Advanced Driver Assistance System
  • Parking Assist System
  • Brake control system
  • Electric Control Suspension
  • Airbags
  • Functional Safety Technology
  • Transmission Control
  • Start-Stop System
  • Electronic Power Steering System
  • Other Applications

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia and Pacific
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Automotive Piston System Industry Expected to Reach USD 6,415.14 Million by 2032, Expanding at a 4.6% CAGR | FMI Reports

Automotive Piston System Market
Automotive Piston System Industry

The global automotive piston system industry is expected to grow at a steady CAGR of 4.6% from 2022 to 2032. With a valuation of USD 4,080.95 million in 2022, it is projected to reach USD 6,415.14 million by 2032. According to historical analysis from Future Market Insights, the market was valued at USD 3,880.91 million in 2021.

This growth is expected to be fueled by the rising demand for automobiles, particularly in emerging economies, where the increasing production of vehicles directly drives the demand for pistons, which are crucial components in internal combustion engines. Additionally, the growing trend for lightweight pistons in the automotive industry is set to further accelerate the expansion of the automotive piston system market over the forecast period.

Key Takeaways

  • The sales of cars in a variety of categories, including two-wheelers, four-wheelers, and other automobile segments, are expected to rise along with the global automotive piston system market.
  • The demand for pistons is anticipated to increase even further due to the booming automobile market, particularly in the two-wheeler segment across emerging countries like India. This will favourably affect the global automotive piston system market.
  • As opposed to conventional single-cylinder engines, double-cylinder engines are quickly becoming more popular in the two-wheeler business. Within the high-end cycling market, this is typical. Additionally, it only needs one piston because a double engine cylinder requires two pistons as opposed to one. The global automotive piston system market is anticipated to grow in tandem with the increased production of high-end motorcycles.
  • In the upcoming years, it is anticipated that rising demand for passenger automobiles and heavy commercial vehicles will fuel the expansion of the global automotive piston system market.
  • The automobile business is constantly conducting research and development to increase fuel efficiency because fuel prices are rising globally. As a consequence, there is an increase in demand for lightweight pistons on the global market for automotive piston systems.
  • The growing use of electric vehicles is one of the biggest issues the global automotive piston industry is currently dealing with. Pistons are not typically used in these cars. Additionally, engine downsizing for lighter, more fuel-efficient engines is another restriction on the worldwide automotive piston market.
  • Utilizing technologies like turbochargers, automakers are able to downsize engines by greatly reducing the number of cylinders while still keeping engine power. Over the course of the evaluation period, the aforementioned factors are anticipated to pose a serious threat to the market for automotive piston systems.

Comprehensive Market Insights: Full Report Overview

Competitive Landscape

Prominent players in the global automotive piston system market are focusing on adopting strategies of new product development in order to retain their leading position in the automotive piston market.

Some of the key participants present in the global Automotive piston system market include MAHLE GmbH (Germany), Aisin Seiki Co., Ltd. (Japan), Rheinmetall Automotive AG (Germany), Tenneco Inc. (US), and Art Metal Mfg. Co. Ltd. (Japan). MAHLE GmbH adopted the strategies of new product development to retain its leading position in the automotive piston market.

Key Segments Covered in the Automotive Piston System Industry Report

Vehicle Type:

  • Two Wheelers
  • Passenger Cars
  • LCV
  • HCV

Piston Material:

  • Aluminium
  • Steel

Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East & Africa

More Insights into the Automotive Piston System Industry

Throughout the forecast period, Asia Pacific is expected to dominate the global automotive piston system market by accounting for the largest share of the market. Furthermore, the largest share on the basis of vehicle production is attributed to the Asia Pacific market. This segment is expected to be dominated by affordable vehicles. The majority of which are hatchbacks, compact sedans, and compact SUVs. Moreover, the majority of these vehicles are powered by a four-cylinder engine. Given these considerations, the passenger car segment is expected to have the highest demand for pistons in the coming years.

Europe is anticipated to create lucrative growth opportunities over the projection period as it is home to major automotive assembly and production plants. In Europe, there have been estimated 297 vehicle assembly plants. Furthermore, the need for lightweight pistons to improve performance is the primary factor driving the growth of the European automotive piston market.

The European automotive piston market is expected to augment over the assessment period at an impressive CAGR of 5.4% from 2022 to 2032. The market is propelling due to several technological advancements in ICEs, such as intelligent combustion management systems and fuel efficiency improvements to achieve power advantages and lower emission levels, which are emerging as new trends supporting the growth of the European automotive piston market.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube